Characteristics of the 101 Hemophilic Patients Included in the Study
| . | Treated (n = 50) . | Untreated (n = 51) . | P Value . |
|---|---|---|---|
| Age (yr)* | 33 (14-54) | 34 (14-61) | NS |
| Hemophilia A | |||
| Mild | 7 (14%) | 10 (20%) | |
| Moderate | 7 (14%) | 6 (12%) | |
| Severe | 26 (52%) | 26 (51%) | NS |
| Hemophilia B | 7 (14%) | 6 (12%) | |
| von Willebrand disease | 3 (6%) | 3 (6%) | |
| ALT (IU/L)* | 125 (27-455) | 135 (34-312) | NS |
| Cirrhosis | 3 (6%) | 2 (4%) | NS |
| HCV-RNA | |||
| MEq/mL† | 1.5 (<0.2-11.0) | 1.1 (<0.2-13.9) | <.03 |
| No. with genotype 1a | 26 (52%) | 19 (37%) | |
| 1b | 10 (20%) | 9 (18%) | |
| 2 | 3 (6%) | 9 (18%) | NS |
| 3a | 11 (22%) | 14 (27%) | |
| HGV-RNA pos | 5 (10%) | 3 (6%) | NS |
| . | Treated (n = 50) . | Untreated (n = 51) . | P Value . |
|---|---|---|---|
| Age (yr)* | 33 (14-54) | 34 (14-61) | NS |
| Hemophilia A | |||
| Mild | 7 (14%) | 10 (20%) | |
| Moderate | 7 (14%) | 6 (12%) | |
| Severe | 26 (52%) | 26 (51%) | NS |
| Hemophilia B | 7 (14%) | 6 (12%) | |
| von Willebrand disease | 3 (6%) | 3 (6%) | |
| ALT (IU/L)* | 125 (27-455) | 135 (34-312) | NS |
| Cirrhosis | 3 (6%) | 2 (4%) | NS |
| HCV-RNA | |||
| MEq/mL† | 1.5 (<0.2-11.0) | 1.1 (<0.2-13.9) | <.03 |
| No. with genotype 1a | 26 (52%) | 19 (37%) | |
| 1b | 10 (20%) | 9 (18%) | |
| 2 | 3 (6%) | 9 (18%) | NS |
| 3a | 11 (22%) | 14 (27%) | |
| HGV-RNA pos | 5 (10%) | 3 (6%) | NS |